|
ATG4C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.527900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.752800E-01 |
| Normal-vs-Stage2 |
5.088600E-01 |
| Normal-vs-Stage3 |
5.139300E-03 |
| Normal-vs-Stage4 |
2.165900E-04 |
| Stage1-vs-Stage2 |
6.806000E-01 |
| Stage1-vs-Stage3 |
1.089940E-02 |
| Stage1-vs-Stage4 |
1.115330E-03 |
| Stage2-vs-Stage3 |
2.544400E-01 |
| Stage2-vs-Stage4 |
1.539620E-01 |
| Stage3-vs-Stage4 |
6.240800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.788100E-02 |
| Normal-vs-AfricanAmerican |
1.606230E-04 |
| Normal-vs-Asian |
4.857000E-01 |
| Caucasian-vs-AfricanAmerican |
3.643100E-03 |
| Caucasian-vs-Asian |
9.749600E-01 |
| AfricanAmerican-vs-Asian |
2.713200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.804100E-02 |
| Normal-vs-Female |
2.952000E-02 |
| Male-vs-Female |
6.404400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.666000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.965440E-01 |
| Normal-vs-Age(61-80Yrs) |
3.347500E-02 |
| Normal-vs-Age(81-100Yrs) |
4.406100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.025200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.137600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.547800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.299400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.512800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.733600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.274800E-01 |
| Normal-vs-Grade 2 |
9.810000E-01 |
| Normal-vs-Grade 3 |
2.100800E-03 |
| Normal-vs-Grade 4 |
1.65399999999538E-05 |
| Grade 1-vs-Grade 2 |
3.607200E-01 |
| Grade 1-vs-Grade 3 |
4.135500E-02 |
| Grade 1-vs-Grade 4 |
2.839100E-03 |
| Grade 2-vs-Grade 3 |
4.080700E-03 |
| Grade 2-vs-Grade 4 |
2.32789999999872E-05 |
| Grade 3-vs-Grade 4 |
2.534300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.921160E-01 |
| Normal-vs-ccB subtype |
4.606500E-04 |
| ccA subtype-vs-ccB subtype |
1.46420000002312E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.330640E-01 |
| Normal-vs-N1 |
1.304220E-01 |
| N0-vs-N1 |
3.542600E-01 |
|
|
